Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18.

PHASE3CompletedINTERVENTIONAL
Enrollment

2,067

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Infections, Papillomavirus
Interventions
BIOLOGICAL

HPV-16/18 L1/AS04

Trial Locations (61)

100

GSK Investigational Site, Taipei

333

GSK Investigational Site, Tao Yuan County

805

GSK Investigational Site, Bogotá

5006

GSK Investigational Site, North Adelaide

5053

GSK Investigational Site, Bergen

10315

GSK Investigational Site, Berlin

10967

GSK Investigational Site, Berlin

12110

GSK Investigational Site, Alcora/Castellón

12539

GSK Investigational Site, Alquerías Del Niño Perdido (Castellón)

18109

GSK Investigational Site, Rostock

18147

GSK Investigational Site, Rostock

18246

GSK Investigational Site, Bützow

22307

GSK Investigational Site, Hamburg

24937

GSK Investigational Site, Flensburg

24939

GSK Investigational Site, Flensburg

24943

GSK Investigational Site, Flensburg

24944

GSK Investigational Site, Flensburg

24955

GSK Investigational Site, Harrislee

25541

GSK Investigational Site, Brunsbüttel

25813

GSK Investigational Site, Husum

25821

GSK Investigational Site, Bredstedt

25899

GSK Investigational Site, Niebüll

27000

GSK Investigational Site, Évreux

27130

GSK Investigational Site, Verneuil-sur-Avre

27180

GSK Investigational Site, Saint-Sébastien-de-Morsent

27270

GSK Investigational Site, Broglie

27940

GSK Investigational Site, Aubevoye

28046

GSK Investigational Site, Madrid

28210

GSK Investigational Site, Nogent-le-Roi

37000

GSK Investigational Site, Tours

37230

GSK Investigational Site, Luynes

38302

GSK Investigational Site, Wolfenbüttel

44300

GSK Investigational Site, Nantes

44866

GSK Investigational Site, Bochum

46017

GSK Investigational Site, Valencia

47798

GSK Investigational Site, Krefeld

47877

GSK Investigational Site, Willich

54290

GSK Investigational Site, Trier

68167

GSK Investigational Site, Mannheim

73326

GSK Investigational Site, Deggingen

75014

GSK Investigational Site, Paris

77694

GSK Investigational Site, Kehl

77955

GSK Investigational Site, Ettenheim

82362

GSK Investigational Site, Weilheim

97070

GSK Investigational Site, Würzburg

97941

GSK Investigational Site, Tauberbischofsheim

99425

GSK Investigational Site, Weimar

Unknown

GSK Investigational Site, Perth

GSK Investigational Site, Bogotá

GSK Investigational Site, Pont-de-l'Arche

GSK Investigational Site, Comayagüela

GSK Investigational Site, Ciudad de Panama - La Chorrera

GSK Investigational Site, Castellon

500 02

GSK Investigational Site, Hradec Králové

532 03

GSK Investigational Site, Pardubice

0370

GSK Investigational Site, Oslo

133--792

GSK Investigational Site, Seoul

08037

GSK Investigational Site, Barcelona

SE-631 88

GSK Investigational Site, Eskilstuna

SE-581 85

GSK Investigational Site, Linköping

SE-701 85

GSK Investigational Site, Örebro

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00196924 - Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18. | Biotech Hunter | Biotech Hunter